Medscape Diabetes & Endocrinology Editorial Board

Editorial Board — Medscape Diabetes & Endocrinology

Board Members

Harpreet S. Bajaj. MD, MPH
- Research Associate
  Leadership Sinai Center for Diabetes
  Mount Sinai Hospital
  Endocrinologist
  LMC Diabetes & Endocrinology
  Brampton, Ontario, Canada
Aaron R. Chidakel, MD
- New York University Langone Medical Center
  New York, New York
Vivian Fonseca, MD
- Tulane University Health Sciences Center
  New Orleans, Louisiana
Per-Henrik Groop, MD, DMSc
- University of Helsinki
  Helsinki University Hospital
  Helsinki, Finland
Simon R. Heller, MB BChir, DM, FRCP
- University of Sheffield School of Medicine
  Sheffield, South Yorkshire, United Kingdom
Akshay B. Jain, MD, FACE, CCD, ECNU, DABOM
- Wockhardt Hospital, Fraser Riner Endocrinology
  Vancouver, British Columbia, Canada

Scott Kahan, MD, MPH
- Johns Hopkins University
  George Washington University
  Washington, DC
Angela M. Leung, MD, MSc
- UCLA David Geffen School of Medicine
  Los Angeles, California
Jessica Sparks Lilley, MD
- Mississippi Center for Advanced Medicine
  Madison, Mississippi
Anne L. Peters, MD, CDE
- Keck School of Medicine
  University of Southern California
  Los Angeles, California
Arya M Sharma, MD, PhD, DSc
- University of Alberta
  Edmonton, Alberta
Dace L. Trence, MD
- University of Washington
  Seattle, Washington

Board Member Details

Harpreet S. Bajaj, MD, MPH

Research Associate, Leadership Sinai Center for Diabetes, Mount Sinai Hospital; Endocrinologist, LMC Diabetes & Endocrinology, Brampton, Ontario, Canada

Harpreet S. Bajaj, MD, MPH, had disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Diabetes Canada; LMC Healthcare
Received research grant from: Amgen; AstraZeneca; Boehringer Ingelheim; Eli Lilly and Company; Janssen; Kowa; Merck; Novo Nordisk; Public Health Agency of Canada; Sanofi; Tricida
Received income in an amount equal to or greater than $250 from: Canadian Collaborative Research Network; CPD Network; Eli Lilly and Company; Humber River Hospital; mdBriefCase; Medscape; Novo Nordisk

[ Back to Top ]

Aaron R. Chidakel, MD

Assistant Clinical Professor, New York University Langone Medical Center, New York, New York

Aaron R. Chidakel, MD, has disclosed no relevant financial relationships.

[ Back to Top ]

Vivian Fonseca, MD

Professor of Medicine; Assistant Dean for Clinical Research; Tullis-Tulane Alumni Chair in Diabetes; Section Chief, Department of Endocrinology, Tulane University Medical Center, New Orleans, LA

Vivian Fonseca, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: BRAVO4Health
Received research grant from: Fractyl; Jaguar Gener Therapy
Received income in an amount equal to or greater than $250 from: Novo Nordisk; Sanofi; Bayer; Abbott; Astra-Zeneca; Asahi

[ Back to Top ]

Per-Henrik Groop, MD, DMSc (PhD),

Professor of Internal Medicine, Faculty of Medicine, University of Helsinki; Chief Physician, Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Per-Henrik Groop, MD, DMSc (PhD), has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Astellas; AstraZeneca; Boehringer Ingelheim; Eli Lilly; Elo Water; Medscape; MundiPharma; MSD; PeerVoice; SCIARC
Received income in an amount equal to or greater than $250 from: Astellas; AstraZeneca; Boehringer Ingelheim; Eli Lilly; Elo Water; Medscape; MundiPharma; MSD; PeerVoice; SCIARC

[ Back to Top ]

Simon R. Heller, MB BChir, DM, FRCP

Professor of Clinical Diabetes, Department of Oncology and Metabolism, University of Sheffield; Consultant Physician, Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals, Sheffield, South Yorkshire

Simon R. Heller, MB BChir, DM, FRCP, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Vertex; Zealand Pharma; Zucara Therapeutics
Serve(d) as a speaker or member of a speakers bureau for: Novo Nordisk Received research grant from: Dexcom
Received income in an amount equal to or greater than $250 from: NovoNordisk

[ Back to Top ]

Akshay B. Jain, MD

Endocrinologist, Clinical Instructor, University of British Columbia, Vancouver, British Columbia

Askay B. Jain, MD, FACE, CCD, ENCU, DABOM, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Abbot; Amgen; AstraZeneca; Bausch; Boehringer Ingelheim; Dexcom; Eli Lilly; HLS Therapeutics; Janssen; Merck; Medtronic
Received research grant from: Abbot; Amgen; Novo Nordisk

[ Back to Top ]

Scott Kahan, MD, MPH

Director, National Center for Weight and Wellness; Medical Director, S.T.O.P. Obesity Alliance, George Washington University, Washington DC; Faculty, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland

Scott Kahan, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk; Lilly; Vivus; Gelesis; Currax

[ Back to Top ]

Angela M. Leung, MD, MSc

Associate Professor, Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, UCLA David Geffen School of Medicine; VA Greater Los Angeles Healthcare System, Los Angeles, California

Angela M. Leung, MD, MSc, has disclosed the following relevant financial relationships:
Serve(d) as an editor and a member of the Board of Directors for: American Thyroid Association
Serve(d) as a consultant for: Vertice Pharma

[ Back to Top ]

Jessica Sparks Lilley, MD

Division Chief, Department of Pediatric Endocrinology, Mississippi Center for Advanced Medicine, Madison, Mississippi

Jessica Sparks Lilley, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Omnipod

[ Back to Top ]

Anne L. Peters, MD

Professor, Department of Clinical Medicine, Clinical Scholar, Keck School of Medicine of the University of Southern California; Director, USC Clinical Diabetes Programs, University of Southern California Westside Center for Diabetes, Los Angeles, California

Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or a trustee for: AstraZeneca; Lilly; NovoNordisk; Abbott; Vertex; Zealand; ShouTi
Received research grant from: Insulet; Dexcom; Abbott
Received income in an amount equal to or greater than $250 from: AstraZeneca; Lilly; NovoNordisk; Abbott; Vertex; Zealand; ShouTi; Insulet; Dexcom
Stock options from: Teladoc; Omada Health (not even close to 5% equity)

[ Back to Top ]

Arya M Sharma, MD

Professor Emeritus, Department of Medicine, University of Alberta, Edmonton, Alberta

Arya M Sharma, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Novo Nordisk; Boehringer; Xeno Biosciences; Johnson & Johnson
Serve(d) as a speaker or a member of a speakers bureau for: Novo Nordisk

[ Back to Top ]

Dace L. Trence, MD

Professor, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington

Dace Trence, MD, has disclosed no relevant financial relationships.

[ Back to Top ]